JPRN-UMIN000007308
Completed
N/A
RenalGuard System to Prevent Contrast-Induced Acute Kidney Injury in Japan - RESPECT KIDNEY
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yokohama Sakae Kyosai Hospital
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Class 3 or 4 chronic heart failure. Subject is anuric or has undergone renal replacement therapy, or has a known inability to have a Foley catheter placed. Subject has received contrast within 7 days of procedure. Subject has a known hypersensitivity to furosemide and/or the contrast agent being used.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Protection from Contrast Induced Nephropathy with Remote Ischemic ConditioningSubjects with CKD (eGFR <60ml/min/m2) undergoing elective CAG and PCIJPRN-UMIN000011264Osaka City University270
Recruiting
N/A
the Prevention of Contrast-Induced Nephropathy by Atrial Natriuretic Peptide in Endovascular Aneurysm Repair.patients underwent endovascular aneurysm repairJPRN-UMIN000003909Jikei University, School of Medicine Department of Surgery, Vascular Surgery50
Active, Not Recruiting
Phase 1
Prevention of renal insufficiency caused by contrast mediumEUCTR2014-001838-29-ITG. d'Annunzio University240
Unknown
Phase 3
RenalGuard System for Prevention of Contrast Induced NephropathyRadiographic Contrast Agent NephropathyNCT02029820Hospital Sao Lucas da PUCRS210
Completed
Phase 3
prevention of kidney injury caused by contrast media during angioplasty/graphy by adminstration of sodium potassium citrate solutiocontrast induced nephropathy.Drug- and heavy-metal-induced tubulo-interstitial and tubular conditionsIRCT2015050322065N1Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences190